Skip to content

Abnormal Epidermis Stratum Granulosum Morphology C5539823

Published: July 22, 2026Updated: August 20, 2026

A condition affecting the granular layer of the skin, which plays a key role in the skin barrier. It can occur in various skin disorders and may affect people of any age.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
L98.9
ICD-11
EA00.0
Body system
dermatologic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Skin infection

Secondary bacterial infection developing in cracked or compromised skin barrier.

Seek immediate care if you notice pus, increasing redness, warmth, fever, or spreading infection.

!

Skin blistering

Formation of fluid-filled blisters in severe cases where the epidermal layer is significantly compromised.

Seek prompt medical attention if blisters cover large areas or show signs of infection.

Dry skin

(dermatologic)

The skin feels tight, rough, or flaky due to impaired barrier function in the stratum granulosum.

Frequency: 80-90% of patients

Itchy skin

(dermatologic)

Persistent itching sensation caused by skin barrier dysfunction and increased transepidermal water loss.

Frequency: 75-85% of patients

Scaly skin

(dermatologic)

Visible scaling or flaking of the outer skin layer due to abnormal keratinization.

Frequency: 70-80% of patients

Skin redness

(dermatologic)

Redness or erythema appearing as inflamed patches on affected skin areas.

Frequency: 50-60% of patients

Rough skin texture

(dermatologic)

Abnormally rough or uneven skin surface texture felt upon touch.

Frequency: 45-55% of patients

Skin fissures

(dermatologic)

Cracks or splits in the skin that may be painful, particularly over joints.

Frequency: 35-45% of patients

Skin irritation

(dermatologic)

Localized irritation or discomfort that may worsen with harsh soaps or environmental factors.

Frequency: 40-50% of patients

Skin pain

(neurologic)

Burning, stinging, or painful sensations in affected skin areas due to nerve irritation.

Frequency: 15-25% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dermatological evaluation and biopsy follow-up

Specialist examination with potential repeat biopsy to assess stratum granulosum morphology changes over time. This provides definitive information about the skin structure at a cellular level.

procedure
2

Lifestyle modification and dietary intervention

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
3

Advanced barrier moisturization

Medical-grade moisturizers containing lipid complexes that help restore the stratum granulosum barrier function. Regular application helps maintain hydration and protects against environmental triggers.

medication

Additional treatment options

Environmental trigger avoidance

Identifying and minimizing exposure to harsh soaps, detergents, extreme temperatures, and other environmental factors that may stress the stratum granulosum. Creating a skin-safe home and work environment supports healing.

lifestyle

Essential fatty acid supplementation

Dietary or supplemental omega-3 and omega-6 fatty acids to support skin cell membrane health and barrier function. These essential fats cannot be produced by the body and must be obtained through diet.

dietary

Symptom and skin condition tracking

Keeping a log of skin symptoms, triggers, and treatment responses to help identify patterns and optimize management. Digital photos can supplement written records for objective comparison.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Epidermis Stratum Granulosum Morphology C5539823?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Elmets CA, Korman NJ, Prater EF, et al. Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures. J Am Acad Dermatol. 2021;84(2):432-470.

guideline2021View source →
2

Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol. 2008;17(12):1063-1072.

review2008View source →
3

Menter A, Strober BE, Kaplan DH, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019;80(4):1029-1072.

guideline2019View source →
4

Fitzpatrick's Dermatology in General Medicine. 9th ed. McGraw-Hill; 2023.

textbook2023
5

Sbidian E, Chaimani A, Garcia-Doval I, et al. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis. Cochrane Database Syst Rev. 2022;1(1):CD011535.

meta_analysis2022View source →
6

Thiers BH. The pathogenesis and pathophysiology of psoriasis. J Am Acad Dermatol. 1990;23(5 Pt 2):931-935.

consensus1990View source →
7

Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361(5):496-509.

review2009View source →
8

Gordon KB, Blauvelt A, Papp KA, et al. Phase 3 trials of ixekizumab in moderate-to-severe plaque psoriasis. N Engl J Med. 2016;375(4):345-356.

clinical_trial2016View source →

Medication Comparisons

Compare medications used to treat Abnormal Epidermis Stratum Granulosum Morphology C5539823. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy